PSYK ETF (PSYK)

NYSEARCA: PSYK · Delayed Price · USD
17.88
-0.39 (-2.15%)
At close: May 24, 2022 4:00 PM
17.88
0.00 (0.00%)
After-hours:May 24, 2022 8:00 PM EDT
Assets$729,000
NAV$18.23
Expense Ratio0.75%
PE Ration/a
Shares Out40,000
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
1-Year Return-14.87%
Volume480
Open18.41
Previous Close18.27
Day's Range17.86 - 18.05
52-Week Low16.71
52-Week High22.40
Beta1.44
Holdings26
Inception DateJan 31, 2022

About PSYK

The fund adviser uses a "passive management" (or indexing) approach to track the performance of the index. The index is a rules-based index that tracks the performance of a portfolio of companies that have business activity in the fields of psychedelic treatment used to address medical conditions in legal pharmacological applications under the applicable country's laws. The fund will generally invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.

Asset ClassEquity
IssuerExchange Traded Concepts
Stock ExchangeNYSEARCA
Ticker SymbolPSYK
Index TrackedEnhanced Consciousness Index

Top 10 Holdings

64.49% of assets
NameSymbolWeight
Intra-Cellular TherapiesITCI8.61%
Jazz PharmaceuticalsJAZZ8.54%
Biohaven Pharmaceutical Holding Co.BHVN8.26%
Sage TherapeuticsSAGE7.53%
Myriad GeneticsMYGN6.79%
AlkermesALKS5.31%
ATAI Life SciencesATAI5.00%
Relmada TherapeuticsRLMD4.87%
H. Lundbeck A/SLUN.CO4.85%
Neurocrine BiosciencesNBIX4.73%
View More Holdings

News

Diversify Your Portfolio With a New Psychedelic Drug ETF

A new thematic ETF providing exposure to the medicinal psychedelic drug industry, PSYK ETF, has just been launched.

3 months ago - Zacks Investment Research

New Psychedelics ETF Launches On NYSE Arca

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF PSYK tracks the...

3 months ago - Benzinga

3rd Psychedelics ETF Launches

First-time issuer Elemental Advisors is the latest to create an ETF for the burgeoning industry.

3 months ago - ETFcom

Elemental Advisors President Talks Investing in Psychedelics Through PSYK

Elemental Advisors just launched the PSYK ETF (NYSE Arca: PSYK), a thematic ETF focused on the emerging use of psychedelic compounds in treating mental health issues. Tim Collins, a founder and presiden...

3 months ago - ETF Trends

Elemental Advisors Launches PSYK ETF Focused on the Medical Psychedelics Industry

SARASOTA, Fla.--(BUSINESS WIRE)--Elemental Advisors Inc. (“Elemental Advisors”) is pleased to announce the launch of PSYK ETF (NYSE: PSYK), a thematic ETF that tracks the performance of the Enhanced Con...

3 months ago - Business Wire